Binds two Fe³⁺ ions per molecule via bicarbonate-mediated coordination
Isoelectric point varies between plasma and intestinal forms (4.5 vs. 5.5)
Property | Value | Source |
---|---|---|
Plasma concentration | 250 mg/100 ml | |
Iron binding capacity | 1.25 μg Fe/mg protein | |
Thermal stability | Stable at -20°C long-term |
Rat transferrin demonstrates tissue-specific regulation:
Liver: Primary synthesis site with mRNA levels increasing 2.4× during iron deficiency
Brain: Oligodendrocytes produce transferrin independently, showing 83 mRNA copies/cell
Testes: Maintains constant 114 mRNA copies/cell regardless of iron status
Iron transport occurs through two distinct pathways:
The blood-brain barrier exhibits specialized transferrin handling:
Developmental regulation: Transport peaks at 2-3 weeks postnatal (6.5 ng Fe/g brain/hr)
Cellular distribution:
Parameter | Value | Method |
---|---|---|
Kd (brain) | 1.0 nM | ¹²⁵I labeling |
Bmax (cortex) | 12.3 pmol/mg protein | Immunoblot |
Parameter | Intra-assay CV | Inter-assay CV |
---|---|---|
Precision | 5.5% | 10.1% |
OX26 antibody conjugation enables 3.2× increased brain accumulation vs. IgG controls
Chronic dosing (3 mg/kg SQ) reduces plasma clearance by 54× through receptor saturation
Formulation | AUC₀₋₂₄ (μg·min/mL) | Cmax (μg/mL) |
---|---|---|
Naive TfRMAb | 658 ± 196 | 0.76 ± 0.2 |
Pre-dosed TfRMAb | 18 ± 8 | 0.016 ± 0.007 |
Rat transferrin is a monomeric glycoprotein with a molecular weight of approximately 80,000 Da that plays a crucial role in iron metabolism . It functions as the specific iron-binding protein in plasma, responsible for the transportation and distribution of iron among various body organs . Additionally, rat transferrin contributes to iron metabolism, prevents iron loss via the kidney, and possesses bacteriostatic and fungistatic activity . In normal rat plasma, transferrin is found at an average concentration of 250 mg/100ml .
The protein has two primary functions: first, it serves as the main iron transporter in circulation, binding ferric iron with high affinity; second, it facilitates the cellular uptake of iron through receptor-mediated processes . Transferrin is also required by all types of cells in culture for maximal growth, making it an important factor in defined culture media for experimental work .
Rat transferrin shows significant species-specific characteristics in both structure and function. Research indicates fundamental differences between rat and human transferrin, especially in binding characteristics . These differences are particularly important in experimental settings, as human serum supplemented with rat transferrin can support normal growth of cultured rat conceptuses, whereas supplementation with human transferrin does not produce the same effect . This strongly suggests species-specificity in transferrin function and receptor binding.
The binding characteristics of rat transferrin allow it to form both monoferric (one iron atom bound) and diferric (two iron atoms bound) complexes . Studies using acrylamide gel electrophoresis and isoelectric focusing have shown that the distribution of radioiron added in vitro or through absorption is random between the binding sites of slow and fast transferrin molecules in rats .
Rat transferrin gene expression exhibits notable tissue-specific regulation. In normal rats, the liver expresses the highest levels of transferrin mRNA, with approximately 6500 molecules per cell . Other tissues express transferrin at lower levels: brain (83 molecules per cell), testis (114 molecules per cell), and even lower amounts in spleen and kidney . The small intestine has no detectable transferrin mRNA in either normal or iron-deficient rats, despite the presence of transferrin protein .
Research suggests that intestinal transferrin in rats is not synthesized locally but originates in the liver and is transported to the gut via bile . This hypothesis is supported by several findings:
The small intestine shows no detectable transferrin mRNA in either normal or iron-deficient rats, yet transferrin protein is present and its level is 2-fold higher in iron-deficient rats .
Bile transferrin content is elevated in iron deficiency and appears sufficient to account for intestinal transferrin levels .
Treatment of plasma transferrin with bile causes an acidic shift in its isoelectric-focusing behavior, making it comigrate with intestinal transferrin .
This pathway represents an important physiological mechanism for delivering transferrin to the intestinal mucosa and may play a role in regulating iron absorption in response to body iron status .
For precise quantification of rat transferrin mRNA in tissue samples, researchers have successfully employed hybridization assays using single-stranded [32P]RNA probes specific for transferrin . This approach allows for accurate measurement of transferrin mRNA levels across different tissues.
The methodology involves:
Isolation of total RNA from tissue samples
Hybridization with a transferrin-specific labeled RNA probe
Quantification using standards of known concentration
Expression of results as molecules per cell (assuming 7 pg of DNA per rat cell)
For measuring transcription rates, nuclear transcription assays using in vitro elongation with isolated nuclei can be employed . After transcription in the presence of [32P]UTP, RNA is isolated and hybridized to filters containing rat transferrin cDNA. The hybridization efficiency should be measured using an appropriate internal standard .
Researchers can distinguish between different forms of rat transferrin using several techniques:
Isoelectric focusing (IEF): This technique effectively separates transferrin variants based on their isoelectric points and has been successfully used to differentiate between plasma transferrin and intestinal transferrin . IEF can also track modifications in transferrin after treatment with bile or other substances.
Acrylamide gel electrophoresis: This method separates transferrin based on molecular weight and charge, allowing for the identification of different forms .
Iron-binding status detection: The monoferric and diferric forms of transferrin can be distinguished using radioactive iron labeling techniques. Studies have shown that iron binding with iron chelates at 30 min is 93%-98% effective, while binding with simple ferric salts is reduced to 71%-76% .
Receptor binding assays: Using antibodies to the rat transferrin receptor can help distinguish forms based on their receptor binding characteristics .
Monoferric and diferric forms of rat transferrin exhibit important differences in their physiological behavior that impact experimental interpretations:
Tissue uptake rates: The diferric form of transferrin demonstrates more rapid tissue uptake of iron compared to the monoferric form . This difference in uptake kinetics is a critical consideration when designing experiments involving iron transport.
Iron exchange dynamics: In iron-loaded animals, monoferric transferrin injected into plasma is rapidly loaded with iron from tissues and converted to diferric transferrin . Conversely, in iron-deficient animals, injected diferric transferrin rapidly disappears from circulation, with subsequent appearance of monoferric transferrin as iron returns from tissues .
Tissue distribution: Despite differences in uptake rates, the distribution pattern of iron among body tissues is similar for both monoferric and diferric transferrin iron and is not affected by the site distribution of iron on the transferrin molecule .
These observations support the concept that plasma iron generally behaves as a single pool, with the key distinction being that diferric iron exchange occurs at a more rapid rate than monoferric iron exchange .
Rat cells utilize both receptor-mediated (saturable) and non-receptor-mediated (non-saturable) pathways for transferrin and iron uptake. Research on rat hepatocytes has revealed several key findings:
Receptor-mediated pathway: This high-affinity, specific process involves transferrin receptors on the cell surface. Treatment with an antibody to the rat transferrin receptor almost completely eliminates the saturable uptake of iron . This pathway is the predominant mechanism at low transferrin concentrations.
Non-receptor-mediated pathway: This low-affinity, non-saturable process becomes increasingly important at higher iron-transferrin concentrations. When both rat albumin and anti-transferrin receptor antibody are present, iron uptake decreases to approximately 15% of normal at low transferrin concentrations (0.5 μM), but only to 40% at higher concentrations (5 μM) .
Albumin effect: The presence of rat serum albumin reduces the endocytosis of transferrin by cells but has no significant effect on intracellular iron accumulation . The maximum effect of rat serum albumin is observed at concentrations of 3 mg/ml and above .
These dual pathways ensure efficient iron uptake across a wide range of physiological conditions and transferrin concentrations.
Iron deficiency induces a specific upregulation of transferrin gene transcription in rat liver, with several notable characteristics:
Transcriptional activation: The increase in transferrin mRNA levels during iron deficiency (2.4-fold higher than normal) results specifically from increased transcriptional activity of the transferrin gene, as measured in isolated nuclei .
Tissue specificity: This transcriptional response is highly tissue-specific, occurring in the liver but not in other tissues that express transferrin, such as brain and testis .
Quantitative changes: In normal rat liver, transferrin mRNA levels are approximately 6500 molecules per cell, increasing to about 15,600 molecules per cell in iron-deficient conditions .
Functional consequences: The increased transferrin gene expression results in a corresponding increase in serum total-iron-binding capacity, enhancing the organism's ability to capture and transport iron during deficiency states .
This regulatory mechanism represents an important physiological adaptation to iron deficiency, allowing the organism to maximize iron transport efficiency when this essential nutrient is limited.
When designing experiments involving rat transferrin in cell culture systems, several methodological considerations should be addressed:
Species specificity: Due to the significant differences between rat and human transferrin, researchers should use rat transferrin when working with rat cells . Human transferrin does not adequately support rat cell systems, indicating important species-specific interactions .
Iron saturation status: The iron saturation status of transferrin significantly affects its cellular uptake and function. Complete and specific binding of iron by transferrin can be demonstrated after in vitro or in vivo addition of ferrous ammonium sulfate in pH 2 saline up to the point of iron saturation .
Albumin presence: The presence of albumin in culture media reduces transferrin endocytosis but may have limited effect on iron accumulation . For optimal results, rat serum albumin at concentrations of 3 mg/ml or higher should be considered .
Storage conditions: Commercial rat transferrin is typically available as a lyophilized product and should be stored at temperatures ≤ -20°C to maintain stability .
Buffer conditions: For experimental work, rat transferrin is commonly prepared in 20 mM NaH₂PO₄, pH 7.4, with 150 mM NaCl .
To effectively model iron deficiency for studying transferrin regulation, researchers should consider the following methodological approach:
Dietary manipulation: Rats raised on a low-iron diet provide an excellent model system for investigating the regulation of transferrin gene expression by iron deficiency . This approach induces physiological responses without the confounding effects of anemia-inducing agents.
Verification methods: Iron status should be verified through multiple parameters:
Serum iron levels
Total iron-binding capacity (TIBC)
Transferrin saturation percentage
Hemoglobin levels
Tissue iron stores (especially liver)
Timing considerations: The duration of iron restriction should be carefully controlled to achieve the desired degree of iron deficiency while avoiding severe anemia that might introduce secondary effects.
Control groups: Proper control groups fed standard iron-sufficient diets are essential for comparison, with animals matched for age, sex, and strain.
Tissue collection: When examining tissue-specific effects, multiple tissues should be collected simultaneously (liver, brain, testis, spleen, kidney, intestine) to allow for comparative analysis of transferrin expression patterns .
This approach has successfully demonstrated the 2.4-fold increase in liver transferrin mRNA levels and subsequent increase in serum total-iron-binding capacity in iron-deficient rats .
When faced with contradictory findings regarding transferrin localization or expression, researchers should consider several factors:
Detection method sensitivity: Different detection methods have varying sensitivity thresholds. For example, transferrin mRNA may be undetectable in intestinal tissue using standard hybridization techniques, despite the presence of transferrin protein . In such cases, more sensitive methods or alternative approaches (such as examining protein origin) may be needed.
Post-translational modifications: Transferrin undergoes modifications that can affect its detection and apparent localization. Treatment of plasma transferrin with bile causes an acidic shift in its isoelectric-focusing behavior, potentially leading to misidentification .
Transport mechanisms: Transferrin found in certain tissues may originate elsewhere. The intestinal transferrin paradox (protein present despite no mRNA) was resolved by identifying liver synthesis and bile transport as the source .
Experimental conditions: Iron status significantly affects transferrin expression and distribution. When comparing studies, researchers must account for differences in animal iron status, which can dramatically alter transferrin levels and distribution patterns .
Species differences: When comparing findings across studies, researchers should be aware that significant species-specific differences exist in transferrin biology . Data from one species may not directly translate to another.
Several methodological challenges can affect the accurate measurement of rat transferrin receptor-mediated iron uptake:
Non-specific binding: At higher transferrin concentrations, the relative contribution of non-saturable (non-receptor-mediated) iron uptake increases significantly . Failure to account for this dual-pathway system can lead to misinterpretation of receptor-mediated uptake data.
Albumin interference: The presence of albumin reduces transferrin endocytosis but may have limited effect on iron accumulation . Experiments should control for albumin concentration, as it can significantly impact results at levels of 3 mg/ml and above .
Iron saturation variability: The iron saturation status of transferrin significantly affects uptake rates, with diferric transferrin showing more rapid tissue uptake than monoferric forms . Researchers should carefully control and document the iron saturation status of transferrin preparations.
Antibody specificity: When using antibodies to block receptor-mediated uptake, their specificity must be verified. Antibodies to the rat transferrin receptor almost completely eliminate saturable uptake of iron but have little effect on the non-saturable process .
Cell type variations: Different cell types may exhibit varying ratios of receptor-mediated versus non-receptor-mediated uptake. Findings from one cell type (such as hepatocytes) should not be generalized to all rat cells without verification .